Status:
UNKNOWN
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19
Lead Sponsor:
Rennes University Hospital
Conditions:
ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2
Acute Refractory Heart Failure Related to SARS-CoV 2
Eligibility:
All Genders
Brief Summary
The role of ECMO in the treatment of patients with severe COVID-19 (Acute Respiratory Distress Syndrome (ARDS) and/or acute refractory heart failure) is not yet known. The present study will aim to re...
Detailed Description
The main objective of this study is to evaluate the hospital survival of COVID-19 patients supported by venovenous or venoarterial ECMO in a multicenter registry. The secondary objectives are to desc...
Eligibility Criteria
Inclusion
- All COVID-19 patients, adults or children,
- Tested positive by RT-PCR for SARS-CoV2 (nasopharyngeal swabs, sputum, endotracheal aspiration, bronchoalveolar lavage or stool sample) and / or with a diagnosis made on chest CT findings,
- Supported by venovenous or venoarterial ECMO
Exclusion
- Temporary legally protected Adults over a set period or waiting for protection supervision, guardianship
- Patients or proxies who express their opposition to study participation
Key Trial Info
Start Date :
April 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 21 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04397588
Start Date
April 21 2020
End Date
October 21 2020
Last Update
August 31 2020
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers University Hospital
Angers, France, 49933
2
Besançon Hospital
Besançon, France, 25030
3
Brest university Hospital
Brest, France, 29200
4
Caen University Hospital
Caen, France, 14033